Specialised therapies in targeted indications
Merck Serono is committed to improving the lives of people with a range of endocrine and metabolic disorders including growth
hormone deficiency and diabetes.
Merck Serono was a pioneer in making recombinant human growth hormone available for the treatment of growth hormone deficiency
in children and adults. Merck Serono continues to bring benefits to patients through its treatments and its family of easy-to-use
drug delivery devices.
Merck Serono pursues focused development in Endocrinology.
More about:
| Disclaimer |
| This section gives an overview of our Company's activities in endocrinology. The information may refer to pharmaceutical products, therapeutics or indications not yet registered or approved in a given country. |
